BIOMAT Database Logo BIOMAT Database Logo

Tuberculous epididymo-orchitis after intravesical BCG therapy for superficial bladder carcinoma: sonographic findings. 2007

Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
Radiology Department, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain. rsalvadoriz@gmail.com

UI MeSH Term Description Entries
D008297 Male Males
D009920 Orchitis Inflammation of a TESTIS. It has many features of EPIDIDYMITIS, such as swollen SCROTUM; PAIN; PYURIA; and FEVER. It is usually related to infections in the URINARY TRACT, which likely spread to the EPIDIDYMIS and then the TESTIS through either the VAS DEFERENS or the lymphatics of the SPERMATIC CORD. Orchitides
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000283 Administration, Intravesical The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms. Bladder Drug Administration,Drug Administration, Bladder,Instillation, Bladder,Intravesical Drug Administration,Administration, Intravesical Drug,Injections, Intravesical,Intravesical Administration,Intravesical Injection,Intravesical Instillation,Administration, Bladder Drug,Administrations, Bladder Drug,Administrations, Intravesical,Administrations, Intravesical Drug,Bladder Drug Administrations,Bladder Instillation,Bladder Instillations,Drug Administration, Intravesical,Drug Administrations, Bladder,Drug Administrations, Intravesical,Injection, Intravesical,Instillation, Intravesical,Instillations, Bladder,Instillations, Intravesical,Intravesical Administrations,Intravesical Drug Administrations,Intravesical Injections,Intravesical Instillations
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D014389 Tuberculosis, Male Genital MYCOBACTERIUM infections of the male reproductive tract (GENITALIA, MALE). Male Genital Tuberculosis,Genital Tuberculoses, Male,Genital Tuberculosis, Male,Male Genital Tuberculoses,Tuberculoses, Male Genital

Related Publications

Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
Tuberculous epididymo-orchitis following intravesical BCG for superficial bladder cancer.
January 2002, Le Journal medical libanais. The Lebanese medical journal,
Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
Tuberculous epididymo-orchitis following intravesical BCG.
July 1990, British journal of urology,
Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
Tuberculous epididymo-orchitis: sonographic findings.
January 1991, Journal of clinical ultrasound : JCU,
Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
Late occurrence of bilateral tuberculous-like epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma.
January 2005, Urology,
Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
Sonographic findings in tuberculous epididymo-orchitis.
January 2004, Journal of clinical ultrasound : JCU,
Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
Preoperative diagnosis of bilateral tuberculous epididymo-orchitis following intravesical Bacillus Calmette-Guerin therapy for superficial bladder carcinoma.
June 2002, Australasian radiology,
Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
Tuberculous epididymitis and epididymo-orchitis: sonographic findings.
July 1993, The Journal of urology,
Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
Sonographic findings in tuberculous epididymitis and epididymo-orchitis.
September 1997, Journal of clinical ultrasound : JCU,
Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
Tuberculous epididymitis and epididymo-orchitis: sonographic appearances.
June 2001, AJR. American journal of roentgenology,
Rafael Salvador, and Ramon Vilana, and Xavier Bargalló, and Xavier Araque, and Carlos Nicolau
A Case of Epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma in a patient with latent tuberculosis infection.
January 2016, Infectious agents and cancer,
Copied contents to your clipboard!